Furosemide reduces BK-αβ4-mediated K+ secretion in mice on an alkaline high-K+ diet

Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F341-F350. doi: 10.1152/ajprenal.00223.2018. Epub 2018 Nov 28.

Abstract

Special high-K diets have cardioprotective effects and are often warranted in conjunction with diuretics such as furosemide for treating hypertension. However, it is not understood how a high-K diet (HK) influences the actions of diuretics on renal K+ handling. Furosemide acidifies the urine by increasing acid secretion via the Na+-H+ exchanger 3 (NHE3) in TAL and vacuolar H+-ATPase (V-ATPase) in the distal nephron. We previously found that an alkaline urine is required for large conductance Ca2+-activated K+ (BK)-αβ4-mediated K+ secretion in mice on HK. We therefore hypothesized that furosemide could reduce BK-αβ4-mediated K+ secretion by acidifying the urine. Treating with furosemide (drinking water) for 11 days led to decreased urine pH in both wild-type (WT) and BK-β4-knockout mice (BK-β4-KO) with increased V-ATPase expression and elevated plasma aldosterone levels. However, furosemide decreased renal K+ clearance and elevated plasma [K+] in WT but not BK-β4-KO. Western blotting and immunofluorescence staining showed that furosemide treatment decreased cortical expression of BK-β4 and reduced apical localization of BK-α in connecting tubules. Addition of the carbonic anhydrase inhibitor, acetazolamide, to furosemide water restored urine pH along with renal K+ clearance and plasma [K+] to control levels. Acetazolamide plus furosemide also restored the cortical expression of BK-β4 and BK-α in connecting tubules. These results indicate that in mice adapted to HK, furosemide reduces BK-αβ4-mediated K+ secretion by acidifying the urine.

Keywords: furosemide; high-K diet; large conductance Ca-activated K; urine pH.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acid-Base Equilibrium
  • Animals
  • Diet*
  • Female
  • Furosemide / pharmacology*
  • Hydrogen-Ion Concentration
  • Kidney / drug effects*
  • Kidney / metabolism
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits / metabolism*
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits / deficiency
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits / genetics
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits / metabolism*
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Potassium / blood
  • Potassium / metabolism*
  • Potassium / urine
  • Renal Elimination / drug effects*
  • Sodium Potassium Chloride Symporter Inhibitors / pharmacology*
  • Vacuolar Proton-Translocating ATPases / metabolism

Substances

  • Kcnmb4 protein, mouse
  • Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
  • Large-Conductance Calcium-Activated Potassium Channel beta Subunits
  • Sodium Potassium Chloride Symporter Inhibitors
  • Furosemide
  • Vacuolar Proton-Translocating ATPases
  • Potassium